Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies - Top-Institutions - MDSpire

Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies

  • By

  • Pupu Li

  • Xia Xue

  • Zisen Zhang

  • June 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    Huazhong University of Science and Technology
    Huazhong University of Science and Technology

    Wuhan, Hubei

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies

  • by Pupu Li, Xia Xue, Zisen Zhang

  • June 11, 2026

Related Content

Obesity-driven metabolic reprogramming and immune dysfunction in renal cancer

The unheard pain: why patient-related barriers remain the weakest link in cancer pain management

Construction and validation of a preoperative malignancy risk prediction model for ovarian-adnexal masses based on clinical and ultrasonographic features